Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Improving HIV coreceptor usage prediction in the clinic using hints from next-generation sequencing data.

Nico Pfeifer1, Thomas Lengauer

  • 1Department of Computational Biology and Applied Algorithmics, Max Planck Institute for Informatics, Campus E1 4, 66123 Saarbrücken, Germany. nico.pfeifer@mpi-inf.mpg.de

Bioinformatics (Oxford, England)
|September 11, 2012
PubMed
Summary

Accurate prediction of HIV drug resistance is crucial for effective treatment. This study introduces a new method using all next-generation sequencing data to improve predictions, benefiting even labs without advanced sequencing capabilities.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PP-GWAS: Privacy Preserving Multi-Site Genome-wide Association Studies.

Nature communications·2025
Same author

Geno2pheno: recombination detection for HIV-1 and HEV subtypes.

NAR molecular medicine·2025
Same author

Privacy-preserving AUC computation in distributed machine learning with PHT-meDIC.

PLOS digital health·2025
Same author

Target leakage and the use of diagnostic variables in diabetes prediction models.

Nutrition & diabetes·2025
Same author

Privacy-preserving federated unsupervised domain adaptation with application to age prediction from DNA methylation data.

Bioinformatics (Oxford, England)·2025
Same author

Long-term impact of the SARS-CoV-2 pandemic on respiratory viruses in Germany.

BMC public health·2025

Area of Science:

  • Virology
  • Computational Biology
  • Genomics

Background:

  • High mutation rates of human immunodeficiency virus (HIV) lead to frequent emergence of drug-resistant variants.
  • Coreceptor antagonists are a new class of anti-HIV drugs blocking viral entry by targeting CD4 cell coreceptors.
  • Accurate prediction of viral susceptibility to coreceptor antagonists is vital for therapy decisions.

Purpose of the Study:

  • To develop an improved prediction model for HIV coreceptor tropism using next-generation sequencing (NGS) data.
  • To enhance prediction performance for both NGS and Sanger sequencing data.
  • To identify key amino acid positions and residues in the HIV V3 loop influencing coreceptor interaction.

Main Methods:

  • A novel patient-level prediction model was developed, integrating information from all reads in NGS data.

Related Experiment Videos

  • The model was trained on NGS data and its performance was evaluated on both NGS and Sanger sequencing datasets.
  • Analysis was performed to pinpoint specific amino acids and their positions critical for prediction accuracy.

    • Main Results:

    • The patient-level model significantly improved prediction performance for NGS data compared to previous read-based methods.
    • The developed model also enhanced prediction accuracy for Sanger sequencing data, broadening its applicability.
    • Specific amino acid positions within the HIV V3 loop were identified as key determinants of coreceptor tropism.

    Conclusions:

    • The new prediction model offers a more robust approach to determining HIV coreceptor tropism, especially from NGS data.
    • This method benefits a wider range of diagnostic laboratories, including those without NGS capabilities.
    • The findings provide valuable insights into the molecular mechanisms underlying HIV-coreceptor interactions and drug resistance.